At AMP 2022, Immunexpress launches rapid test for sepsis requiring two minutes hands-on time

From Leo O’Connor of

At the Association for Molecular Pathology annual meeting and exposition this week, Immunexpress launched a rapid molecular diagnostic test that could enable ruling in or ruling out sepsis in one hour.

The SeptiCyte Rapid test is different from almost all other sepsis tests on the market by means of its operation directly from a blood draw, Immunexpress CEO Rollie Carlson told LabPulse on the sidelines at AMP in Phoenix.

Read the LabPulse post in its entirety

Leave a Comment